Damora Therapeutics, Inc. (DMRA) — Long-term Investment Intensity
Damora Therapeutics, Inc. (DMRA) has a Long-term Investment Intensity of 8.0% as of December 2022. Long-term investments of $5.83 Million represent 8.0% of total assets of $73.19 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See DMRA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Damora Therapeutics, Inc. Long-term Investment Intensity (2021–2022)
This chart shows how Damora Therapeutics, Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the intensity stands at 8.0%, reflecting long-term investments of $5.83 Million against total assets of $73.19 Million USD. See Damora Therapeutics, Inc. (DMRA) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Damora Therapeutics, Inc. (2021–2022)
The table below presents the year-by-year Long-term Investment Intensity for Damora Therapeutics, Inc. from 2021 to 2022, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Damora Therapeutics, Inc. total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 8.0% | $5.83 Million | $73.19 Million | ▲ +0.6 pp |
| 2021 | 7.4% | $9.05 Million | $122.22 Million | — |